Relay Therapeutics' financial stability is strong, but zero Q3 2024 revenue and rising net losses raise concerns. Find out ...

No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS) reported its financial results for the fourth quarter and full year ending ...

Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-s ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

1 Day RANI 0.72% DJIA -0.75% Russell 2K -0.86% Health Care/Life Sciences 0.29% ...

Investing.com - Rani Therapeutics Holdings reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations. Rani ...

$500 million upfront and a total deal value of up to $5 billion sounds like a deal made by a top-tier pharma company – but, in fact, it comes from diminutive biotech Summit Therapeutics. The ...

New York, USA, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working in the Therapeutics Segment ...

- Completed two equity offerings with total gross proceeds of approximately $20.0 million; cash runway extended into 3Q 2025 - - Announced new preclinical pharmacokinetic data supporting ...

Q: Who is the music director of Rocky Aur Rani Kii Prem Kahaani? A: The music of Rocky Aur Rani Kii Prem Kahaani has been composed by Pritam Chakraborty. Q: Who is the lyricist of Rocky Aur Rani ...